Official recall notice

FDA DrugClass IINotable

FDA Recall: Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Al

Recall date
2026-06-10
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications

Recommended action

What to do

15,696 x 30's bottles

Product description

Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications

Verify with the official notice →
Share:

Related Recalls

2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack further packaged in a carton, Rx
Ascend Laboratories, LLC
2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx o
Ascend Laboratories, LLC
2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx
Ascend Laboratories, LLC
2026-07-29 · FDA_DRUG
FDA Recall: Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactur
Ascend Laboratories, LLC